Collectively, these results indicate that AMDHD1 significantly inhibits the proliferation and migration of CCA cells in vitro and in vivo, underscoring its potential as a therapeutic target in CCA treatment. The gene discussed is AMDHD1; the disease is cholangiocarcinoma.